Fuhan Medical Files for IPO Following Two Rounds of Funding to Advance Pediatric Ophthalmic Precision Diagnostics
Fuhan Medical
Developer of Products and Services in the Field of Children's Eye Health
'%20fill='%23FFFFFF'%3E%3Crect%20x='249'%20y='126'%20width='1'%20height='1'%3E%3C/rect%3E%3C/g%3E%3C/g%3E%3C/svg%3E)
SiYu Annual Activity Review:The First Global Ophthalmology Conference | The First Global Orthopedics Conference | The First Global Cardiovascular Conference
Coming Soon:
June 12, 2025, The First Global Medical Aesthetics Technology Conference
July 17, 2025, The Second Global Medical Technology Conference
September 4-5, 2025, The 3rd Global Surgical Robotics Conference
Recently, committed to the development of products and services in the field of children's eye health,Fuhan MedicalAbbreviation: "Fuhan Medical")AnnouncementCompletedSeries A+ FinancingThe amount was not disclosed. This round of financing was led by the Lianyungang Industrial Investment Fund managed by Jinyu Maowu, with follow-up investments from well-known medical industry investors.
The funds raised will be mainly used forAccelerate the development of multi-modal fundus imaging systems for children, intelligent pediatric vision examination systems, and the world's first contact-based OCT for infant ophthalmology., registration and marketing, helping to break the monopoly of international brands and promoting the global competitiveness of high-end ophthalmic equipment made in China.
The company has alreadyCompletedTens of Millions of Yuan in Series A Financing,The raised funds are used forAccelerate the Kiretem Series Ultra-Wide Field Fundus Camera to Break the Monopoly of International Brands in the Chinese MarketBreak, accelerate the research and development as well as registration of a series of innovative products, and realize the cross-border export of high-quality Chinese products.
# From "No Rice to Cook" to "Self-Developed Breakthrough"
In traditional fundus screening, the bulky medical equipment, complex operation, and high usage threshold have always been significant factors that restrict timely and precise fundus examination for children, especially infants. Now, at the ophthalmology clinic of Nanjing Children's Hospital, a "small but powerful" technological breakthrough is quietly changing this situation:A portable device only the size of a handle, easily completing operations such as patient information entry, fundus photography, and image printing. Its operational flexibility and high integration have overturned people's preconceived notions of fundus cameras.
This device is independently developed by Fuhan Medical "Creton 160-Degree Ultra-Wide Angle Ophthalmic Wide-Field Imaging System". Compared with imported equipment that often weighs up to 200 catties, the product from Coreton allows doctors to perform 'retinal examinations in their pockets,' making it more suitable for the challenging clinical scenario of screening for neonatal retinal diseases. With the help of this device,Early detection of ocular lesions in infants and young children has become more timely, effectively extending the intervention window., also provides a new pathway for primary and specialized medical institutions to obtain fundus images.
Although eye diseases are often associated with aging, vision health issues in newborns should not be overlooked. The China CDC conducted an eye disease screening for nearly 200,000 newborns across the country, and the results showedThe incidence of eye diseases is as high as 9.11%..Once the early intervention opportunity is missed, it may lightly affect the development of visual function and heavily lead to irreversible visual disability. However, for a long time,Newborn Fundus Screening Heavily Relies on Imported Equipment, not only are they expensive and have long procurement cycles, but they are also difficult to maintain, becoming a technical bottleneck that is hard to avoid in clinical practice.
Fuhan Medical Chairman Ren Zhixiang, fully aware of the difficulties, personally visited multiple hospitals in China and foreign suppliers. He witnessed the various inconveniences faced by doctors during the screening process due to heavy equipment and complex operations. "We used to rely on imported equipment, but now even imports are unstable—it’s like ‘having no rice to cook.’" Ren Zhixiang’s words expressed the helplessness of the industry and also signaled a determination to transform—shifting focus toward independent research and development.
He realized that these unmet clinical needs have created significant opportunities for innovation in China-produced products. From identifying pain points to developing product prototypes, from technical challenges to clinical trials, Fuhan Medical quickly invested in technology research and development, attempting to fill this "technological no-man's land" through a localized approach.Breaking the Import Monopoly in the Niche Field of Neonatal Fundus Screening, paving an innovative path for China's medical device enterprises.
# Create the World's First Pediatric Ophthalmology Imaging Platform
Since its official launch in 2020, Fuhan Medical's ophthalmic wide-field imaging system has completed the development and evolution of three generations of products, gradually building up fundus imaging solutions covering multiple age groups, including newborns, infants, and children. Among them,Creighton Series Becomes the World's First Ophthalmic Device for Children to Achieve 160° Ultra-Wide Angle Shooting，Providing 13-megapixel high-definition images,The lens diameter is only 7mm, and the wireless handle weighs just 400 grams.，Surpassing mainstream products with a traditional 130° field of view in terms of shooting range, image quality, and inspection efficiency.
In the past, doctors often had to stitch together more than a dozen photos to obtain a complete image of a newborn's fundus, which was not only time-consuming but also increased the risk of errors and omissions. However, the ultra-wide-angle design by Keruitong typically requires only 4 to 5 images to cover the entire fundus, significantly improving diagnostic efficiency and clinical operability.
In fundus examination for infants and young children, traditional devices often struggle to obtain effective images due to the low cooperation of the patients and the immature structure of the fundus. To address this pain point, Fuhan Medical has also developedWorld's First Contact OCT System for Infants and Toddlers，Capable of achieving posterior ocular segment tomography imaging and quantitative analysis, providing doctors with structural information in the cross-sectional dimension, significantly reducing the risk of missed diagnoses and misdiagnoses.
This not only fills the market gap for infant and pediatric ophthalmic OCT devices globally but also provides a new technological pathway for the early identification of retinal developmental abnormalities and macular diseases. In addition, the Ultra system from Creathon has obtained EU CE certification, marking a key step in the internationalization of China-produced equipment and indicating that Fuhan Medical's original technology now has the capability to compete on par with international giants in the global market.
# Dual Progress in Miniaturization and Intelligence
# Company Profile
Fuhan Medical was established in 2018, with its headquarters and R&D base located in the Nanjing Jiangbei New Area. It is a high-tech small and medium-sized enterprise focusing on the field of children's eye health. The company centers on independent research and development, dedicated to the precise diagnosis and treatment of neonatal and infant fundus diseases. Its products cover areas such as wide-field imaging of pediatric fundus, intelligent vision testing, and optical coherence tomography (OCT). Currently, the company has obtained three registered certificates for ophthalmic wide-field imaging systems.
In 2024, as one of the technical participants, the company was selected for the National Key R&D Program "Research on Prevention and Treatment of Common and Frequently Occurring Diseases" key special project led by Shanghai Jiao Tong University. The project will focus on the early screening and diagnosis of visual impairment diseases in infants, children, and adolescents, and carry out systematic research and development of multimodal fundus imaging and artificial intelligence fusion technology.
Welcome companies to actively participate in the conference organized by Siyu ↓
June 12, 2025, The First Global Medical Aesthetics Technology Conference
July 17, 2025, The Second Global Medical Technology Conference
September 4-5, 2025, The 3rd Global Surgical Robotics Conference
GOC2025
Ophthalmology Solutions Case
Research on Ophthalmic Instruments Industry